United States · Who invested in Agilvax?
Agilvax's investors include National Cancer Institute (NCI).
201520162017201820192020
$1.1MVenture$2.0MSeries A$1.5MSeries A
United States · Series A startup
Who invested in Agilvax
Funding summaryUpdated 26 Oct 2026
$4.7Mraised across 3 rounds since 2014, from 3 sources
$1.1MVenture$2.0MSeries A$1.5MSeries A
- Latest round
- Series A, $1.5MJan 2020
- Biggest round
- $2.0MSeries A · Jul 2014
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.1M Jun 2014
- Biggest round
- $2.0M Series A · Jul 2014
- Usual gap between rounds
- 5.4 years the median of 2
The rounds
- Jan 2020
- Jul 2014Series A$2.0M
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2014
- Jun 2014Venture$1.1M
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Jun 2014
Founders and team
From the SEC filings it signed: 5 on the team.
- Brian BirkExecutive Officer, Directori
- Debora E RamirezExecutive Officeri
- Dee BresciaExecutive Officeri
- Ebetuel PallaresExecutive Officer, Directori
- Joseph PattiExecutive Officer, Directori
On the board, as filediBrad ValeFaith CharlesWaneta Tuttle
Quick answers about Agilvax
How much has Agilvax raised?
Agilvax has raised $4.7M across 3 rounds since 2014.
When did Agilvax last raise?
Agilvax's most recent round was a Series A of $1.5M in Jan 2020.
What was Agilvax's biggest round?
Agilvax's largest round on record is $2.0M (Series A), in Jul 2014.
Who backed Agilvax first?
Agilvax's first round on record, in Jan 2020, was backed by National Cancer Institute (NCI).
What stage is Agilvax at?
Agilvax's latest named round is a Series A, in Jan 2020.
Where is Agilvax based?
Agilvax is based in the United States.
Companies like Agilvax
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.